Elsevier

Life Sciences

Volume 33, Issue 4, 25 July 1983, Pages 317-321
Life Sciences

Anticonflict action of sodium valproate. Interaction with convulsant benzodiazepine (Ro 5-3663) and imidazodiazepine (Ro 15-1788)

https://doi.org/10.1016/S0024-3205(83)80003-4Get rights and content

Summary

The possibility that Ro 15-1788, a specific benzodiazepine antagonist would reverse the anxiolytic effect of VPA (200 mg/kg) in the Geller-Seifter paradigm was tested, using male albino rats. VPA (200 mg/kg) induced disinhibition which was antagonized by a convulsant benzodiazepine, Ro 5-3663 (1 mg/kg), but not by imidazobenzodiazepine, Ro 15-1788 at doses of 10 mg/kg, or 30 mg/kg. However, Ro 15-1788 (30 mg/kg) did have a short lasting antagonistic effect on VPA when tested in a “condensed” form (see text) of the conflict test. The nature of the anticonflict potency of VPA is discussed.

References (28)

  • G. Anlezark et al.

    Biochem. Pharmacol.

    (1976)
  • L. Cook et al.

    Brain Res. Bull.

    (1979)
  • H. Lal et al.

    Neuropharm.

    (1980)
  • R.L. MacDonald et al.

    Brain. Res.

    (1979)
  • M. Morag et al.

    Life Sci.

    (1982)
  • M. Myslobodsky et al.

    Electroenceph. Clin. Neurophvsiol.

    (1981)
  • R.A. O’Brien et al.

    Life Sci.

    (1980)
  • M.K. Ticku et al.

    Brain. Res.

    (1981)
  • J.K. Barker
  • L. Cook et al.
  • E. Costa et al.

    Life Sci.

    (1975)
  • J. FELDON, T. LERNER, D. LEVIN, & M. MYSLOBODSKY, Pharmacol. Biochem. Behav. (in...
  • R.F. Furchgott

    Ann. Rev. Pharmacol.

    (1964)
  • K. Gale et al.

    Science

    (1980)
  • Cited by (0)

    View full text